Free Trial

Victrex (OTCMKTS:VTXPF) Stock Price Down 9% - What's Next?

Victrex logo with Basic Materials background

Key Points

  • Victrex PLC's stock price saw a significant decline of 9%, trading as low as $8.99 before recovering slightly to $9.19 during mid-day trading on Friday.
  • Despite the drop, Deutsche Bank reaffirmed a "buy" rating on Victrex's shares, indicating potential investor confidence.
  • The company operates in the polymer solutions market, focusing on segments like Sustainable Solutions and Medical, with a strong balance sheet reflected in its low debt-to-equity ratio of 0.13.
  • Five stocks we like better than Victrex.

Shares of Victrex PLC (OTCMKTS:VTXPF - Get Free Report) fell 9% during trading on Friday . The company traded as low as $8.99 and last traded at $9.19. 685 shares changed hands during trading, an increase of 1,589% from the average session volume of 41 shares. The stock had previously closed at $10.10.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Victrex in a research report on Wednesday, April 16th.

Check Out Our Latest Stock Analysis on VTXPF

Victrex Stock Performance

The company's 50 day moving average price is $10.35 and its 200-day moving average price is $11.06. The company has a quick ratio of 1.58, a current ratio of 3.81 and a debt-to-equity ratio of 0.13.

About Victrex

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.

Recommended Stories

Should You Invest $1,000 in Victrex Right Now?

Before you consider Victrex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.

While Victrex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines